down arrow

Rossari Biotech

  • Market Cap: Small Cap
  • Industry: Chemicals
  • ISIN: INE02A801020
  • NSEID: ROSSARI
  • BSEID: 543213
INR
670.00
-16.85 (-2.45%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 40.77 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

661.45687.00

52 Week

568.05966.00
Valuation
Technical
Day's Volume

CASH

40.77 k (43.81%) Volume

Shareholding (Dec 2024)

FII

3.74%

Held by 67 FIIs

DII

17.47%

Held by 16 DIIs

Promoter

68.19%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Negative results in Dec 24

  • ROCE(HY) Lowest at 15.85 %
  • CASH AND CASH EQUIVALENTS(HY) Lowest at Rs 27.38 cr
  • PBT LESS OI(Q) Lowest at Rs 41.83 cr.
2

Stock is technically in a Mildly Bearish range

3

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Chemicals

stock-summary
Market cap

INR 3,709 Cr (Small Cap)

stock-summary
P/E

28.00

stock-summary
Industry P/E

41

stock-summary
Dividend Yield

0.07%

stock-summary
Debt Equity

0.07

stock-summary
Return on Equity

12.41%

stock-summary
Price to Book

3.40

Revenue and Profits (1 Year):
Net Sales:
513 Cr
(Quarterly Results - Dec 2024)
Net Profit:
32 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.07%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-21.83%
0%
-21.83%
1 Year
-5.42%
0.07%
-5.35%
2 Years
-1.46%
0.14%
-1.32%
3 Years
-33.03%
0.17%
-32.86%
4 Years
-39.95%
0.16%
-39.79%
5 Years
0%
0%
0.0%

Latest dividend: 0.5 per share ex-dividend date: Aug-16-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
31.97%
EBIT Growth (5y)
20.61%
EBIT to Interest (avg)
14.62
Debt to EBITDA (avg)
0.37
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.64
Tax Ratio
25.67%
Dividend Payout Ratio
2.11%
Pledged Shares
0
Institutional Holding
21.21%
ROCE (avg)
22.99%
ROE (avg)
12.11%
Valuation key factors
Factor
Value
P/E Ratio
28
Industry P/E
41
Price to Book Value
3.40
EV to EBIT
19.99
EV to EBITDA
14.98
EV to Capital Employed
3.24
EV to Sales
1.97
PEG Ratio
3.44
Dividend Yield
0.07%
ROCE (Latest)
16.39%
ROE (Latest)
12.41%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 7 Schemes (13.25%)

FIIs

Held by 67 FIIs (3.74%)

Promoter with highest holding

Edward Menezes (29.12%)

Highest Public shareholder

Sbi Small Cap Fund (5.27%)

Individual Investors Holdings

9.51%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 2.89% vs 1.78% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -10.27% vs 1.23% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "512.73",
          "val2": "498.35",
          "chgp": "2.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "64.76",
          "val2": "65.94",
          "chgp": "-1.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.94",
          "val2": "3.68",
          "chgp": "34.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "31.70",
          "val2": "35.33",
          "chgp": "-10.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.63%",
          "val2": "13.23%",
          "chgp": "-0.60%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 10.51% vs 3.94% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 12.96% vs 18.19% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "988.00",
          "val2": "894.07",
          "chgp": "10.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "130.82",
          "val2": "121.31",
          "chgp": "7.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.37",
          "val2": "11.35",
          "chgp": "-35.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "70.23",
          "val2": "62.17",
          "chgp": "12.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.24%",
          "val2": "13.57%",
          "chgp": "-0.33%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 10.52% vs 8.68% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 5.56% vs 23.35% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,500.73",
          "val2": "1,357.84",
          "chgp": "10.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "195.58",
          "val2": "184.98",
          "chgp": "5.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12.31",
          "val2": "15.67",
          "chgp": "-21.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "101.93",
          "val2": "96.56",
          "chgp": "5.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.03%",
          "val2": "13.62%",
          "chgp": "-0.59%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 10.55% vs 11.66% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 21.84% vs 9.82% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,830.56",
          "val2": "1,655.88",
          "chgp": "10.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "249.76",
          "val2": "223.02",
          "chgp": "11.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "19.37",
          "val2": "22.32",
          "chgp": "-13.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "130.69",
          "val2": "107.26",
          "chgp": "21.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.64%",
          "val2": "13.47%",
          "chgp": "0.17%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
512.73
498.35
2.89%
Operating Profit (PBDIT) excl Other Income
64.76
65.94
-1.79%
Interest
4.94
3.68
34.24%
Exceptional Items
0.00
0.00
Consolidate Net Profit
31.70
35.33
-10.27%
Operating Profit Margin (Excl OI)
12.63%
13.23%
-0.60%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 2.89% vs 1.78% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -10.27% vs 1.23% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
988.00
894.07
10.51%
Operating Profit (PBDIT) excl Other Income
130.82
121.31
7.84%
Interest
7.37
11.35
-35.07%
Exceptional Items
0.00
0.00
Consolidate Net Profit
70.23
62.17
12.96%
Operating Profit Margin (Excl OI)
13.24%
13.57%
-0.33%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 10.51% vs 3.94% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 12.96% vs 18.19% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,500.73
1,357.84
10.52%
Operating Profit (PBDIT) excl Other Income
195.58
184.98
5.73%
Interest
12.31
15.67
-21.44%
Exceptional Items
0.00
0.00
Consolidate Net Profit
101.93
96.56
5.56%
Operating Profit Margin (Excl OI)
13.03%
13.62%
-0.59%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 10.52% vs 8.68% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 5.56% vs 23.35% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,830.56
1,655.88
10.55%
Operating Profit (PBDIT) excl Other Income
249.76
223.02
11.99%
Interest
19.37
22.32
-13.22%
Exceptional Items
0.00
0.00
Consolidate Net Profit
130.69
107.26
21.84%
Operating Profit Margin (Excl OI)
13.64%
13.47%
0.17%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 10.55% vs 11.66% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 21.84% vs 9.82% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Rossari Biotech Ltd stock-summary
stock-summary
Rossari Biotech Ltd
Small Cap
Chemicals
Rossari Biotech Limited was founded in 2003 as a partnership firm in the name of Rossari Labtech by Mr. Edward Walter Menezes, and Mr. Sunil Srinivasan Chari, who are both career-technocrats cumulatively having over 45 years of experience in the specialty chemicals industry. It was further renamed to Rossari Biotech Limited and converted into a company in 2009.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."